Form 8-K - Current report:
SEC Accession No. 0001193125-25-242643
Filing Date
2025-10-17
Accepted
2025-10-17 17:20:22
Documents
13
Period of Report
2025-10-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d41718d8k.htm   iXBRL 8-K 31112
  Complete submission text file 0001193125-25-242643.txt   192300

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA oaccu-20251017.xsd EX-101.SCH 3521
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oaccu-20251017_def.xml EX-101.DEF 14316
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE oaccu-20251017_lab.xml EX-101.LAB 23857
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oaccu-20251017_pre.xml EX-101.PRE 15214
16 EXTRACTED XBRL INSTANCE DOCUMENT d41718d8k_htm.xml XML 7443
Mailing Address 333 SOUTH GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071
Business Address 333 SOUTH GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071 213-830-6300
Oaktree Acquisition Corp. III Life Sciences (Filer) CIK: 0002029769 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42383 | Film No.: 251401587
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)